Re: [Gnumed-devel] Re: Drug interactions software -- significance and design considerations

[Eric MAEKER]

Le 3 août 10 à 22:19, Karsten Hilbert a écrit :

> On Tue, Aug 03, 2010 at 12:09:15PM -0700, Jim Busser wrote:
>
> > > Larger vendors will often point to the yearly fees they have to  
> > > pay to their middleware vendors as the justification for the  
> > > higher maintenance fees and to some degree this is true.
>
> Same here and I do think it makes sense.
>
> > This, with FreeDiams, is not the case, however I can
> > understand how companies which bring in revenues might spend
> > extra time to improve their data sources.
>
> The data sources can indeed be improved. Checking drug
> status (on market etc), checking literature for
> interactions, ...

Yes all this can be improved. I've added to the SVN, in BSD licence,  
all scripts for the drugs databases creation.
All improvements may start from this app : FreeToolBox.

> > What should be the thinking about allowing users to
> > contribute interactions to FreeDiams, and of providing the
> > references?
>
> I tend to think that 99%

99,99% ;)

> of all users will not participate.

About 0.0001% will donate.
About 0.1% will review the application on the web.

> The rest are 50% crazy and 50% really sane. The trick is the
> identify the latter. IMO there's no difference to meatspace
> - building relationships.

Whatever is the FreeToolBox will be usable by anyone who wants to  
participate without any knowledge of informatics.
Users will be able to :

        - create drugs databases (Fr, Ca, Us, Za for now)
	- work on the molecules to ATC links (a specific and easy interface  
will be provided)
        - work on documentation (need some work)

Eric